Prescient Therapeutics LimitedASX: PTX

PTX-200 AML Trial Progresses to Higher Dose

Apr 23, 2021 at 2:59 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment